The β-adrenoceptor blocking, vasorelaxant and hypotensive activities of eugenolol (1-(isopropylamino)-3-[(4-allyl-2-methoxy-)phenoxy]-2-propanol) were investigated under in vivo and in vitro conditions. In pentobarbital anesthetized rats, eugenolol (0.1, 0.5, 1.0 mg/kg, i.v.) produced a dose-depende
Ferulidilol: A vasodilatory and antioxidant adrenoceptor and calcium entry blocker, with ancillary β2-agonist activity
✍ Scribed by Yeun-Chih Huang; Jwu-Lai Yeh; Bin-Nan Wu; Yi-Ching Lo; Jhy-Chong Liang; Young-Tso Lin; Sheng-Hsiung Sheu; Ing-Jun Chen
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 246 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
✦ Synopsis
Intravenous injection of ferulidilol (0.5, 1.0, 1.5 mg kg -1 ) produced dose-dependent hypotensive and bradycardia responses in pentobarbital-anesthetized Wistar rats. Ferulidilol competitively antagonized (-)isoprenaline-induced positive inotropic and chronotropic effects of the atria and tracheal relaxation responses on isolated guinea pig tissues. The parallel shift to the right of the concentrationresponse curve of (-)isoprenaline suggested that ferulidilol was a β-adrenoceptor antagonist. The apparent pA 2 values were 8.04 ± 0.09 for the right atria, 8.03 ± 0.15 for the left atria, and 7.51 ± 0.06 for the trachea, respectively. Ferulidilol was more potent than labetalol. In thoracic aorta experiments, ferulidilol also produced a competitive antagonism of norepinephrine-and CaCl 2 -induced contraction with pA 2 and pKCa -1 values of 7.05 ± 0.03 and 6.04 ± 0.05, respectively. Ferulidilol produced cumulative relaxation responses on isolated tracheal strips from reserpine-treated guinea pigs. The effects were competitively antagonized by ICI 118,551 (10 -8 -10 -6 M), a relatively selective β 2 -adrenoceptor antagonist. The results implied that ferulidilol had partial β 2 -agonist activity. In the radioligand binding assay, ferulidilol produced dose-dependent inhibition of [ 3 H]CGP-12177 binding to rat ventricle and lung membranes with K i values of 3.40 and 17.94 nM, respectively. In addition, ferulidilol also antagonized [ 3 H]prazosin and [ 3 H]nitrendipine binding to rat brain membrane with K i values of 32.48 and 305.01 nM, respectively. These results further confirmed the α/β and calcium entry blocking activities of ferulidilol described in functional studies. Furthermore, ferulidilol (10 -8 -10 -5 M] inhibited lipid peroxidation induced by Fe 2+ and ascorbic acid, indicating that it possesses the antioxidant activity inherent in ferulic acid. Our results demonstrate that ferulidilol is a new generation α/βadrenoceptor blocker with ancillary calcium entry blockade, partial β 2 -agonist activities and additional antioxidant effects.
📜 SIMILAR VOLUMES
The combination of β-adrenoceptor blockade and vasodilator action have proved highly useful in antihypertensive therapy. Studies of the mechanisms of action of labedipinedilol-A that combine these effects within a single molecule are described in this report. Intravenous labedipinedilol-A (0.1-1.0 m